Biotech & Health
AI Is Starting to Reshape Clinical Trials
AI is being used to match patients, select trial sites, analyse clinical data and support drug development as AI-designed candidates reach later-stage trials.
8 articles
AI is being used to match patients, select trial sites, analyse clinical data and support drug development as AI-designed candidates reach later-stage trials.
AI biotech startup Enveda raises $311 million to advance nature-derived drug candidates into human clinical trials.
Anthropic confirms it operates a wet biology lab in the Bay Area where AI models support physical experiments focused on fundamental biology research.
OpenAI researcher Miles Wang is reportedly leaving the company to launch an AI drug discovery startup, with funding talks valuing the venture at about $2 billion.
Anthropic introduces Claude Science, a research workbench that helps scientists manage workflows, analyse data, and accelerate discoveries using existing Claude AI models.
Reid Hoffman is leaving Microsoft’s board after nearly a decade to dedicate more time to Manus, his AI-driven drug discovery startup. The LinkedIn co-founder plans to focus on innovation…
Imperagen has raised £5 million to combine quantum physics and artificial intelligence for enzyme engineering, accelerating biotechnology research and industrial innovation.
AI is generating more drug candidates than ever, but one startup is working to identify which ones have real clinical value and market potential.
Written by the reporters who cover each beat. Unsubscribe in one click.